From: MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients
Mi RNA in BAL | Log (fold change) (mean ± s.d.) | p value | |
---|---|---|---|
Control | NSCLC patients | ||
miR-19b-1 | 0.010 ± 0.001 | 0.580 ± 0.03 | 0.001* |
miR-1285 | 0.096 ± 0.021 | 0.18 ± 0.11 | 0.001* |
miR-1289 | 0.169 ± 0.122 | 0.301 ± 0.02 | 0.001* |
miR-1303 | 0.074 ± 0.025 | 0.188 ± 0.02 | 0.001* |
miR-217 | 019 ± 0.087 | 0.199 ± 0.064 | 0.001* |
miR-29a-5p | − 0.250 ± − 0.098 | 0.99 ± 0.2 | 0.001* |
miR-548-3p | 0.199 ± 0.036 | 0.98 ± 0.11 | 0.001* |
miR-650 | − 0.033 ± − 0.079 | 0.94 ± 0.133 | 0.001* |
miR-106a | 1.842 ± 0.504 | 3.22 ± 0.02 | 0.001* |
miR-106-b | 0.44 ± 0.01 | 1.95 ± 0.08 | 0.001* |
miR-143 | − 0.7 ± − 0.0125 | 0.095 ± 0.011 | 0.001* |
miR-10-b | − 0.33 ± − 0.004 | 0.331 ± 0.023 | 0.001* |
miR-1 | 4.72 ± 0.28 | 2.68 ± 0.11 | 0.001* |
miR-30a | 2.82 ± 0.12 | 0.11 ± 0.098 | 0.001* |